back to Canada directory
canada clinical guidance

Vitamin D deficiency — assessment, supplementation, and treatment

A Canadian clinical summary of vitamin d deficiency — assessment, supplementation, and treatment, with source-attributed priorities and explicit jurisdiction boundaries.

JurisdictionCanada
Source check2026-08-20
Clinical reviewiatroX editorial team · Clinical editorial review · reviewed 2026-08-20 · due 2027-08-20
AudienceHealthcare professionals practising in Canada
This is an iatroX educational summary of named Canada sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. British Columbia is used as an explicit Canadian implementation example, not as a national rule. Verify the equivalent pathway, formulary and escalation route in the patient’s province or territory.

British Columbia source: bounded use

This British Columbia source governs appropriate vitamin D testing, not a pan-Canadian treatment regimen for established deficiency. Product choice, replacement dose and monitoring are intentionally omitted pending an exact current treatment source.
sources for this section:BC vitamin D testing

Source-attributed clinical priorities

  • Do not use population-wide 25-hydroxyvitamin D screening; the British Columbia protocol limits testing to defined clinical indications.
  • Distinguish a decision about whether to test from osteoporosis prevention or empiric age-appropriate supplementation.
  • When specialist testing is indicated, state the clinical question and interpret the result with calcium, kidney, liver and malabsorption context.
  • The linked British Columbia protocol addresses appropriate testing and must not be cited as a national replacement-dose guideline.
sources for this section:BC vitamin D testing

Practical assessment and management workflow

1
Identify the exact reason a 25-hydroxyvitamin D result would change management before ordering it.
2
Review malabsorption, kidney or liver disease, metabolic bone disease, medicines and specialist involvement that may justify targeted testing.
3
Avoid repeat testing after routine supplementation when no source-defined indication exists.
4
If a deficiency result is obtained, use an independently verified local treatment source and product information rather than inferring a regimen from this testing protocol.
sources for this section:BC vitamin D testing

Safety, red flags and urgent escalation

  • Symptomatic hypocalcemia or severe metabolic bone disease requires urgent assessment outside a routine testing pathway.
  • Possible toxicity, granulomatous disease or hyperparathyroidism requires calcium and specialist-context review.
  • Do not use this testing protocol to justify very large intermittent replacement doses or a universal numeric treatment target.
sources for this section:BC vitamin D testing

Confirm the local pathway before acting

British Columbia is used as an explicit Canadian implementation example, not as a national rule. Verify the equivalent pathway, formulary and escalation route in the patient’s province or territory.
sources for this section:BC vitamin D testing

Source and implementation boundary

Read this educational summary with the linked source, current Canadian product information where medicines are involved, and the applicable provincial or territorial pathway. Local formularies, reporting duties, referral routes and service availability can differ.
sources for this section:BC vitamin D testing

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. Government of British ColumbiaVitamin D Testing ProtocolEffective 2019-09-01; current BC protocol checked 2026-08-20 · accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page’s provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what—if anything—you may change. Suggestions are never inserted automatically.Browse the Canada question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.